![](/img/cover-not-exists.png)
First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers
Van Eldik, Linda J., Sawaki, Lumy, Bowen, Karen, Laskowitz, Daniel T., Noveck, Robert J., Hauser, Byron, Jordan, Lynn, Spears, Tracy G., Wu, Huali, Watt, Kevin, Raja, Shruti, Roy, Saktimayee M., WatteJournal:
Clinical Pharmacology in Drug Development
DOI:
10.1002/cpdd.795
Date:
April, 2020
File:
PDF, 567 KB
2020